The Live Discharge Rate Trap: Why CMS Just Froze Payments to 400+ California Hospices — and How to Check Yours Before You’re Next.

The April 2026 Qlarant suspension letters all lean on a single statistic: live discharge rate, including transfers. Letters seen so far cite rates anywhere from the mid-50% range up to 100% — compared to a national hospice non-death discharge rate of roughly 17–18%. The audit window appears to cover any rate over roughly 40%, meaning anything from twice the national average on up is in the flag zone for the Federal Task Force’s AI. This post explains how that statistic works, what rates are actually normal, and how to audit your own hospice before you’re next.

For the broader context, see our overview of the April 2026 CMS sweep. This post focuses on the metric itself — because even if you didn’t get a letter, this is the number CMS is going to keep watching.

What “Live Discharge Rate” Actually Measures

A live discharge is any end of a hospice benefit period for a reason other than the patient’s death. The category includes:

• Revocation — the patient chose to stop hospice care (often to pursue curative treatment)
• Discharge for cause — rare; typically safety or behavioral
• Discharge due to no longer terminally ill — the patient no longer meets the six-months-or-less prognosis
• Transfer — the patient moved to another hospice
• Moved out of service area

The “including transfers” phrase in the Qlarant letters matters. Some internal hospice metrics exclude transfers; CMS is explicitly not excluding them.

What Rates Are Actually Normal

Published benchmarks vary depending on the data year and how transfers are handled, but the consistent picture across MedPAC and OIG reporting is:

• National hospice non-death discharge rate: ~17–18% (2021 data; recent years similar)
• Typical hospice: live discharge rates of 10–25% are generally within the expected distribution
• MedPAC flag territory: once you hit the top decile of live discharge rates, regulators pay attention
• Historical OIG fraud cases: non-death discharge rates of 80%+ have been associated with organized fraud schemes (for example, Lolita Beronilla Minerd’s hospice was cited at 85% non-death discharge against a national 17.2% benchmark)

The 40%-and-up range covered by the Qlarant audit window — with letters seen so far citing actual rates from the mid-50% range up to 100% — sits in the space between “unusual” and “almost certainly fraudulent.” That is exactly the band the AI-assisted review is designed to surface. CMS is not claiming an elevated rate is proof of fraud; it’s claiming such a rate is a credible allegation under 42 C.F.R. § 405.370(a), which is a much lower bar.

The Underlying Rule CMS Is Applying

The regulatory hook is 42 C.F.R. § 418.22. Hospice care is covered only when a physician certifies the patient is terminally ill, with a medical prognosis of six months or less if the terminal illness runs its normal course. The CMS theory behind the elevated discharge rate:

If a hospice is admitting patients and then discharging most of them alive, the underlying certifications may not have been supported by the clinical picture. Either the patient wasn’t actually terminally ill with a six-month prognosis, or the prognosis wasn’t properly documented. Either way, the claims may not have met Medicare coverage requirements.

That theory is rebuttable on a claim-by-claim basis — but the statistic triggers the investigation, and the investigation freezes payments.

Legitimate Reasons for Elevated Live Discharge

Real hospices have real reasons for higher-than-average live discharge rates. Reviewers know this. A solid rebuttal will identify which of these patterns applies to your hospice and back it with documentation:

• Long-stay patients who improve. Some patients plateau or improve on hospice — particularly patients admitted with cardiac or neurologic conditions where trajectory is harder to predict.
• Cap-related discharges. Hospices near the aggregate cap sometimes discharge patients who no longer meet the prognosis requirement. That’s appropriate — but it has to be documented as no-longer-eligible, not as a business decision.
• Revocations. Patients change their minds. Seeking curative treatment is their right.
• Transfers for clinical reasons. Geographic relocation, level-of-care needs, specialized care.
• Patient populations with harder-to-predict trajectories. Dementia and some cardiac populations have higher-than-average live discharge rates when care is delivered appropriately.

None of these defenses work as blanket statements. They work only when the underlying documentation for each discharged patient shows the clinical reasoning in real time.

How to Audit Your Own Live Discharge Rate

Every California hospice — and every hospice in a PPEO state — should run this calculation this week.

Step 1: Pull Your Data

Match the window CMS is using. The Qlarant letters referenced discharges between January 1, 2025 and March 30, 2026. Use the same window, then also calculate trailing 12 months to see the current direction.

Step 2: Calculate the Rate

Live Discharge Rate = (Live Discharges ÷ Total Discharges) × 100, where:

• Total Discharges = deaths + live discharges over the period
• Live Discharges includes revocations, no-longer-terminal discharges, transfers, discharge for cause, moved out of service area

Do not exclude transfers. The Qlarant letters explicitly include them.

Step 3: Benchmark

Your Rate	Regulatory Risk
Under 20%	Within national distribution — low statistical flag risk
20–30%	Elevated but explainable — document your reasons proactively
30–40%	High statistical flag risk — treat as pre-investigation posture
40%+	Inside the audit window CMS used to justify the April 2026 suspensions

Step 4: Break It Down by Discharge Reason

Total rate is useful. Breakdown is what wins rebuttals. For every live discharge, categorize the reason and document it:

• What clinical finding supported the discharge decision?
• Who made it — physician, IDT?
• Was the decision consistent with the most recent certification narrative?
• If the patient was discharged as no-longer-terminal, does the chart show the change in trajectory?
• If the patient revoked, is the signed revocation form in the chart?

Step 5: Sample Audit Your Certifications

Pick 10 patients who were live-discharged during the window. For each, confirm:

• Initial certification with physician narrative supports six-month prognosis with real clinical findings (not boilerplate)
• Each recertification narrative connects clinical findings to continued eligibility
• Face-to-face documentation is in the chart from the third benefit period forward
• IDT notes reflect the patient’s changing status
• Discharge documentation is complete and consistent with the clinical picture

If any of these are weak on a sample of 10, they are weak across the panel.

Other Statistical Flags CMS Is Watching

Live discharge rate is the headline, but it’s not the only metric the Federal Task Force’s AI reviews. Patterns that appeared in prior fraud cases and are reportedly part of the current methodology include:

• Medical director concentration. One medical director on record at 45 facilities appeared in the April 2026 enforcement reporting.
• Address concentration. 89 hospices registered to a single physical address was publicly cited as a flag pattern.
• Length of stay distributions. Unusually short stays or unusually long stays clustered near cap thresholds.
• Billing near the aggregate cap. Repeated years of cap-adjacent billing with no cap return.
• New enrollments clustered in PPEO states. Especially with ownership changes.

What to Do If Your Rate Is High

1. Don’t panic and don’t mass-discharge. Sudden changes in discharge patterns trigger the same algorithms.
2. Audit your certifications right now. The rebuttal you might need to file next month is built from charts that exist today.
3. Tighten narratives going forward. Physician narratives on every cert and recert should be specific, clinical, and connected to prognosis.
4. Review your admissions criteria and training. If admissions are generating patients who plateau or improve, the problem starts at the front door.
5. Prepare a self-assessment memo. If you’re flagged, having a document that shows you knew your rate, knew why it was elevated, and documented the clinical reasoning is a strong starting point for rebuttal.

Further Reading

• CMS Pauses Medicare Payments for 447 California Hospices: What the Qlarant Letter Means
• The 15-Business-Day Rebuttal Playbook for California Hospices
• Payments Frozen, Payroll Friday: A Cash-Flow Survival Playbook
• PPEO Is Expanding: What Georgia, Ohio, and Other States Need to Know
• MedPAC March 2025 Report to Congress — Hospice Chapter
• 42 C.F.R. § 418.22 — Certification of Terminal Illness (Cornell LII)

The Bottom Line

An elevated live discharge rate — whatever the specific number on a given letter, anywhere from the mid-50% range up to 100% in the cases seen so far, with the underlying audit window covering anything over roughly 40% — didn’t put 447 California hospices in a CMS payment freeze by itself. The statute and the task force did that. But the statistic is the hook everything else hangs on, and it’s the hook CMS will keep using. Any hospice in a PPEO state that doesn’t know its own rate, doesn’t understand why the rate is what it is, and doesn’t have chart-level documentation backing it, is one AI pass away from being the next letter on the stack.